Treatment of nidranash by nasya therapy and Shirodhara

Evaluation of comparative efficacy of Ashwagandha Taila Nasya versus Ashwagandha Taila Shirodhara as against Standard Care Therapy in the management of Primary Insomnia- a three arm parallel study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089846

Enrollment

100

Registered

2025-06-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G988- Other disorders of nervous system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient with Primary insomnia who are willing to give written informed consent for the study, Patient fulfilling ICD 10 criteria for Insomnia F.51.05.and ICD Code 11(Ayush Morbidity Code(patient suffering from Sleeplessness for at least 1 month not associated with other medical conditions, Mental Disorders, Substance use, ISI Score ranging between 8 to 21- mild to moderate) were randomly selected for the study, Patient of Either gender between age group 18 years to 60 years, Patient who are fit for Nasya and Shirodhara ( Nasya Arha) and (Shirodhara Arha), Patient who are not on any kind of drug dependency.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Improvement in sleep quality as per polysomnographyTimepoint: at baseline, 3 months, 6 months	—

Secondary

Measure	Time frame
Improvement in quality of lifeTimepoint: Baseline, 6 months	—

Countries

India

Contacts

Public ContactDr Chitraveena Nibrad

Datta Meghe Institute of Higher Education and Research

drsuple.punam@gmail.com9860667023

Outcome results